Maria J. Rodriguez - Publications

JAK2V617F-positive clonal hematopoiesis in germline BRCA1 versus BRCA2 mutation carriers.

Journal: Leukemia

Published: March 24, 2026

Glucose transport dependency defines a therapeutic vulnerability in JAK2V617F-driven myeloproliferative neoplasms.

Journal: Cell communication and signaling : CCS

Published: February 27, 2026

Frequent and clinically relevant germline DNA repair gene variants in young and familial myeloproliferative neoplasms.

Journal: Blood cancer journal

Published: September 18, 2025

Correction: Activation of PI3K/Akt/mTOR signaling in the tumor stroma drives endocrine therapy-dependent breast tumor regression.

Journal: Oncotarget

Published: May 20, 2025

A Correlative Approach for the Assessment of Porosity in Shale Rocks by Scanning Electron Microscopy.

Journal: Microscopy and microanalysis : the official journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada

Published: November 22, 2024

Exploiting Synthetic Lethality between Germline BRCA1 Haploinsufficiency and PARP Inhibition in JAK2V617F-Positive Myeloproliferative Neoplasms.

Journal: International journal of molecular sciences

Published: October 18, 2023

CDK4/6 are necessary for UCP1-mediated thermogenesis of white adipose tissue.

Journal: Life sciences

Published: December 27, 2022

Targeting mTOR to overcome resistance to hormone and CDK4/6 inhibitors in ER-positive breast cancer models.

Journal: Scientific reports

Published: November 13, 2022

AKT1 and AKT2 isoforms play distinct roles during breast cancer progression through the regulation of specific downstream proteins.

Journal: Scientific reports

Published: November 11, 2016

Activation of PI3K/Akt/mTOR signaling in the tumor stroma drives endocrine therapy-dependent breast tumor regression.

Journal: Oncotarget

Published: April 21, 2015